MIR548AG2

Across TCGA pan-cancer cohorts, MIR548AG2 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR548AG2 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR548AG2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AG2 expression acts as an unfavorable survival marker, although some lineages such as THYM show a favorable association.

COAD, OV, and CHOL are the cancer types where MIR548AG2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.039	0.783	<.001	90	view →
OV	DFS	Tertile	All	0.399	0.553	.007	66	view →
CHOL	DFS	Tertile	All	0.066	0.498	.003	45	view →
KICH	DFS	Tertile	III,IV	0.061	0.788	.009	27	view →
PCPG	OS	Tertile	All	0.671	0.983	<.001	15	view →
SKCM	OS	Tertile	II,III,IV	0.112	0.321	.026	12	view →
THYM	OS	Tertile	All	1.000	0.714	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR548AG2–COAD (OS)

Open the COAD breakdown →